ARTICLE | Clinical News
Compugen preclinical data
October 28, 2013 7:00 AM UTC
In non-obese mice that spontaneously develop autoimmune insulin-dependent diabetes, CGEN-15001 given for 2 weeks prior to manifestation of clinical symptoms prevented the development of Type I diabete...